The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction
Open accessAbstract
Doxorubicin (DOX) is a widely prescribed antineoplastic and although the precise mechanism(s) have yet to be identified, DOX-induced oxidative stress to mitochondrial membranes is implicated in the pathogenic process. Previous attempts to protect against DOX-induced cardiotoxicity with alpha-tocopherol (vitamin E) have met with limited success, possibly as a result of inadequate delivery to relevant subcellular targets such as mitochondrial membranes. The present investigation was designed to assess whether enrichment of cardiac membranes with alpha-ocopherol is sufficient to protect against DOX-induced mitochondrial cardiotoxicity. Adult male Sprague-Dawley rats received seven weekly subcutaneous injections of 2 mg/kg DOX and fed either standard diet or diet supplemented with alpha-tocopherol succinate. Treatment with a cumulative dose of 14 mg/kg DOX caused mitochondrial cardiomyopathy as evidenced by histology, accumulation of oxidized cardiac proteins, and a significant decrease in mitochondrial calcium loading capacity. Maintaining rats on the alpha-tocopherol supplemented diet resulted in a significant (two- to four-fold) enrichment of cardiac mitochondrial membranes with alpha-tocopherol and diminished the content of oxidized cardiac proteins associated with DOX treatment. However, dietary alpha-tocopherol succinate failed to protect against mitochondrial dysfunction and cardiac histopathology. From this we conclude that although dietary vitamin E supplementation enriches cardiac mitochondrial membranes with alpha-tocopherol, either (1) this tocopherol enrichment is not sufficient to protect cardiac mitochondrial membranes from DOX toxicity or (2) oxidative stress alone is not responsible for the persistent mitochondrial cardiomyopathy caused by long-term DOX therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“inefficient electron transfer through ETS complexes I and III has been shown to increase the half-life of the superoxide anion and thus generation of the cellular H2O2 [7].”
From Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? (2010) · cites this paper as [7]
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · cited 1×
“Protein determination was performed as described by Bradford (35) using bovine serum albumin as the standard.”
Method[37] Carbonyl assays for determination of oxidatively modified proteins
Levine, R. L., Williams, J. A., Stadtman, E. P., & Shacter, E. (1994) · Methods in Enzymology · doi:10.1016/s0076-6879(94)33040-9 · Cited by 2,699
[7] Mitochondrial respiratory control and the polarographic measurement of ADP : O ratios
Estabrook, R. W. (1967) · Methods in Enzymology · doi:10.1016/0076-6879(67)10010-4 · Cited by 1,774 · cited 1×
“Respiratory control ratio (RCR) and ADP/O ratio was calculated according to the methods of Estabrook (28).”
MethodAdriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor Response
Myers, C. E., McGuire, W. P., Liss, R. H., Ifrim, I., Grotzinger, K., & Young, R. C. (1977) · Science · doi:10.1126/science.877547 · Cited by 1,111
Zhao, K., Zhao, G.-M., Wu, D., Soong, Y., Birk, A. V., Schiller, P. W., & Szeto, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402999200 · Cited by 782 · cited 1×
“Using these cytoprotective peptides, investigators have shown that mitochondrial oxidative stress and damage are responsible for hydrogen peroxide- and 3-nitropropionic acid-induced cell death as well as myocardial ischemia/reperfusion injury (25).”
BackgroundDavies, K. J., & Doroshow, J. H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35746-0 · Cited by 631
Anthracycline cardiomyopathy monitored by morphologic changes.
Billingham, M. E., Mason, J. W., Bristow, M. R., & Daniels, J. R. (1978) · PubMed · Cited by 586
Doroshow, J. H., & Davies, K. J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35747-2 · Cited by 540 · cited 1×
“Detailed investigations have revealed that DOX accepts electrons from complex I of the mitochondrial respiratory chain to form the unstable semiquinone free radical of the drug (5,11,12).”
Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide Angiocardiography
Alexander, J., Dainiak, N., Berger, H. J., Goldman, L., Johnstone, D., Reduto, L., Duffy, T., Schwartz, P., Gottschalk, A., Zaret, B. L., et al. (1979) · New England Journal of Medicine · doi:10.1056/nejm197902083000603 · Cited by 535 · cited 1×
“Functionally, there occurs a dose-dependent and progressive decline in maximum developed force of the myocardium reflected by a decreased ejection fraction accompanied by a corresponding increase in left-ventricular end-diastolic volume and pressure (3,4).”
BackgroundAdriamycin-induced heart failure: mechanisms and modulation
Singal, P., Li, T., Kumar, D., Danelisen, I., & Iliskovic, N. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007094214460 · Cited by 428 · cited 1×
“These observations could be regarded as substantiating evidence for oxidative stress being associated, perhaps causally, with drug toxicity (10,36,37).”
Background
Cited by
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
Volkova, M., & Russell, R. (2012) · Current Cardiology Reviews · doi:10.2174/157340311799960645 · Cited by 872
“Interestingly, the antioxidant properties of vitamin E have been shown to be ineffective in preventing left ventricular dysfunction in animals treated with doxorubicin [70, 71].”
BackgroundMitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy
Wallace, K. B., Sardão, V. A., & Oliveira, P. J. (2020) · Circulation Research · doi:10.1161/circresaha.119.314681 · Cited by 599
Self-citationDoxorubicin‐Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy
Carvalho, F. S., Burgeiro, A., Garcia, R., Moreno, A. J., Carvalho, R. A., & Oliveira, P. J. (2014) · Medicinal Research Reviews · doi:10.1002/med.21280 · Cited by 569
Self-citationŠtěrba, M., Popelová, O., Vávrová, A., Jirkovský, E., Kovaříková, P., Geršl, V., & Šimůnek, T. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4795 · Cited by 329
Chemotherapy-Induced Weakness and Fatigue in Skeletal Muscle: The Role of Oxidative Stress
Gilliam, L. A. A., & St. Clair, D. K. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3965 · Cited by 324
Mechanisms and management of doxorubicin cardiotoxicity
Shi, Y., Moon, M., Dawood, S., McManus, B., & Liu, P. P. (2011) · Herz · doi:10.1007/s00059-011-3470-3 · Cited by 215
Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis
Kitakata, H., Endo, J., Ikura, H., Moriyama, H., Shirakawa, K., Katsumata, Y., & Sano, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031414 · Cited by 164
Granados-Principal, S., Quiles, J. L., Ramirez-Tortosa, C. L., Sanchez-Rovira, P., & Ramirez-Tortosa, M. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.04.007 · Cited by 163
“chemotherapeutics (Berthiaume et al., 2005).”
BackgroundGuo, R., Xu, W., Jian-cong, L., Mo, L., Hua, X., Chen, P., Wu, K., Zheng, D., & Feng, J. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1554 · Cited by 162
“Several of these agents, including dexrazoxan (27), angiotensin-converting enzyme (ACE) inhibitors (28), β-blockers (29) and vitamin E (30) have been tested in animal models and clinical studies to prevent or reduce these dose-related clinical events.”
BackgroundPolyphenols, autophagy and doxorubicin-induced cardiotoxicity
Shabalala, S. C., Muller, C. J. F., Louw, J., & Johnson, R. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.05.003 · Cited by 149
Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway
Jiang, Q., Chen, X., Tian, X., Zhang, J., Xue, S., Jiang, Y., Liu, T., Wang, X., Sun, Q., Hong, Y., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154439 · Cited by 142
Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused?
Muoio, D. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.11.007 · Cited by 137
“life of the superoxide anion and thus generation of the cellular H2O2 [7].”
BackgroundInfluentialVarela‐López, A., Battino, M. A., Navarro‐Hortal, M. D., Giampieri, F., Forbes-Hernández, T. Y., Romero‐Márquez, J. M., Collado, R., & Quiles, J. L. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110834 · Cited by 133
Marques‐Aleixo, I., Alves, E. S., Mariani, D., Rizo‐Roca, D., Padrão, A. I., Rocha‐Rodrigues, S., Viscor, G., Torrella, J. R., Ferreira, R. M., Oliveira, P. J., et al. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.10.008 · Cited by 122
Self-citationUnderstanding Anthracycline Cardiotoxicity From Mitochondrial Aspect
Huang, J., Wu, R., Chen, L., Yang, Z., Yan, D., & Li, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.811406 · Cited by 118
“Moreover, some antioxidants are able to decrease anthracycline-induced oxidative stress but without preventing mitochondrial dysfunction (Berthiaume et al., 2005), implying that specifically targeting mitochondria-related ROS generation may be requisite.”
BackgroundDoxorubicin‐Induced Cardiomyopathy in Children
Mancilla, T. R., Iskra, B., & Aune, G. J. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c180017 · Cited by 108
“Studies using vitamin E have shown that it does not protect the heart or prevent mitochondrial dysfunction (28, 30).”
Jain, A., Sharma, G., Kushwah, V., Garg, N. K., Kesharwani, P., Ghoshal, G., Singh, B., Shivhare, U. S., Jain, S., & Katare, O. P. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0011 · Cited by 107
Oliveira, P. J., & Wallace, K. B. (2006) · Toxicology · doi:10.1016/j.tox.2005.12.009 · Cited by 105
Self-citationWang, P., Wang, L., Lü, J., Hu, Y., Wang, Q., Li, Z., Cai, S., Liang, L., Guo, K., Xie, J., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.06.005 · Cited by 104
Sardão, V. A., Oliveira, P. J., Holy, J. M., Oliveira, C. R., & Wallace, K. B. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-0932-x · Cited by 103
“Despite the well-documented role of oxidative stress on the pathogenesis of DOX cardiotoxicity, not all antioxidants are eVective cytoprotectives [40, 41].”
BackgroundInfluentialSelf-citationFabiani, I., Aimo, A., Grigoratos, C., Castiglione, V., Gentile, F., Saccaro, L. F., Arzilli, C., Cardinale, D. M., Passino, C., & Emdin, M. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-10063-9 · Cited by 96
Park, S., Yoon, J., Bae, S., Park, M., Kang, C., Ke, Q., Lee, D., & Kang, P. M. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.084 · Cited by 88
“Dietary vitamin E also diminishes oxidative stress but ineffective in mitochondrial dysfunction [35].”
Hydock, D. S., Lien, C., Jensen, B. T., Schneider, C. M., & Hayward, R. (2011) · PubMed · Cited by 87
The effects of doxorubicin on cardiac calcium homeostasis and contractile function
Shinlapawittayatorn, K., Chattipakorn, S. C., & Chattipakorn, N. (2022) · Journal of Cardiology · doi:10.1016/j.jjcc.2022.01.001 · Cited by 82
Lages, E. B., Fernandes, R. S., Silva, J. D. O., Malachias, Â., Cassali, G. D., de Barros, A. L. B., & Ferreira, L. A. M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110876 · Cited by 75
Miranda‐Vilela, A. L., Grisólia, C. K., Longo, J. P. F., Peixoto, R. C. A., de Almeida, M. C., Barbosa, L. C. P., Roll, M. M., Portilho, F. A., Estevanato, L. L. C., Bocca, A. L., et al. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.06.005 · Cited by 74
“It is suggested that vitamin C supplementation during cancer treatmentmay detrimentally affect therapeutic response [58], and our results corroborate this and also another report which demonstrated that although vitamin E reduced doxorubicin-induced hepatotoxicity in rats, it was not successful against doxorubicin-ind…”
ResultChrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation
Lü, J., Li, J., Hu, Y., Guo, Z., Sun, D., Wang, P., Guo, K., Duan, D. D., Gao, S., Jiang, J., et al. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.10.008 · Cited by 68
Luteolin Attenuates Doxorubicin-Induced Cytotoxicity to MCF-7 Human Breast Cancer Cells
Sato, Y., Sasaki, N., Saito, M., Endo, N., Kugawa, F., & Ueno, A. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00780 · Cited by 66
Ascensão, A. A. M. R., Oliveira, P. J., & Magalhães, J. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.05.060 · Cited by 65
“Vitamin E ↓ or = [68,71]”
Self-citationHydock, D. S., Lien, C., Jensen, B. T., Schneider, C. M., & Hayward, R. (2011) · Integrative Cancer Therapies · doi:10.1177/1534735410392577 · Cited by 65
Jirkovský, E., Popelová, O., Staňková, P., Jirkovská, A., Hroch, M., Hašková, P., Doleželová, E., Mičuda, S., Adamcová, M., Šimůnek, T., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.198358 · Cited by 62
Ding, X., Zhang, Y., Pan, P., Long, C., Zhang, X., Zhuo, L., Zhou, Q., Liao, W., & Tan, G. (2022) · Theranostics · doi:10.7150/thno.80066 · Cited by 60
“Several anti-DCM agents have been identified, such as carvedilol, vitamin E, and resveratrol [39-41], but these agents are far from satisfactory [42].”
Venkatakrishnan, C. D., Dunsmore, K., Wong, H. R., Roy, S., Sen, C. K., Wani, A. A., Zweier, J. L., & Ilangovan, G. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.91507.2007 · Cited by 60
“Different approaches, such as supplementation with various antioxidants (1), have been developed to nullify the Doxinduced oxidative stress in the heart.”
BackgroundRetractedLycopene and Chemotherapy Toxicity
Şahin, K., Şahin, N., & Kucuk, O. (2010) · Nutrition and Cancer · doi:10.1080/01635581.2010.509838 · Cited by 57
“Nutrition and Cancer, 62(7), 988–995 Copyright C © 2010, Taylor & Francis Group, LLC ISSN: 0163-5581 print / 1532-7914 online DOI: 10.”
BackgroundIsorhapontigenin protects against doxorubicin-induced cardiotoxicity via increasing YAP1 expression
Wang, P., Wang, M., Hu, Y., Chen, J., Cao, Y., Liu, C., Wu, Z., Shen, J., Lü, J., & Liu, P. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.10.017 · Cited by 57
Novel Therapeutics for Anthracycline Induced Cardiotoxicity
Vuong, J. T., Stein-Merlob, A. F., Cheng, R. K.-H., & Yang, E. H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.863314 · Cited by 55
“However, while administration of vitamin E in rat models of AIC was also associated with decreased ROS production, it failed to prevent mitochondrial dysfunction or cardiac remodeling on histopathology (105).”
BackgroundIto‐Hagiwara, K., Hagiwara, J., Endo, Y., Becker, L. B., & Hayashida, K. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118315 · Cited by 50
Šimůnek, T., Štěrba, M., Popelová, O., Mertlíková‐Kaiserová, H., Adamcová, M., Hroch, M., Hašková, P., Ponka, P., & Geršl, V. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.236 · Cited by 50
“numerous antioxidants to efficiently protect against the chronic type of anthracycline cardiotoxicity (Myers et al., 1983; Berthiaume et al., 2005) further supports this hypothesis.”
BackgroundTargeting Mitochondria and Oxidative Stress in Cancer- and Chemotherapy-Induced Muscle Wasting
Huot, J. R., Baumfalk, D. R., Resendiz, A., Bonetto, A., Smuder, A. J., & Penna, F. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0149 · Cited by 49
“However, when used to prevent mitochondrial damage in DOX-treated rats through dietary supplementation, vitamin E showed preventions of cardiac oxidative damage, but failed to prevent mitochondrial dysfunction (Berthiaume et al, 2005).”
Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology
Liang, Z., He, Y., & Hu, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810617 · Cited by 49
“DOX treatment significantly reduces mitochondrial Ca2+-loading capacity in rat cardiomyocytes [82].”
BackgroundThe beneficial role of exercise in mitigating doxorubicin-induced Mitochondrionopathy
Marques‐Aleixo, I., Alves, E. S., Oliveira, P. J., Moreira, P. I., Magalhães, J., & Ascensão, A. A. M. R. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.01.002 · Cited by 47
Self-citationChen, J., Zhang, S., Pan, G., Lin, L., Liu, D., Liu, Z., Mei, S., Zhang, L., Hu, Z.-H., Chen, J., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117498 · Cited by 47
Gao, S., Li, H., Feng, X., Li, M., Liu, Z., Cai, Y., Lü, J., Huang, X., Wang, J., Li, Q., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.11.007 · Cited by 45
“Unfortunately, antioxidants including vitamin E [6], N-acetyl cysteine [7] and flavonoid 7-monohydroxyethylrutoside [8] failed to attenuate cardiac symptoms in animal models or in clinical trials, suggesting that Dox cardiotoxicity is amultifactorial process.”
BackgroundŠtěrba, M., Popelová, O., Šimůnek, T., Mazurová, Y., Potáčová, A., Adamcová, M., Mertlíková‐Kaiserová, H., Poňka, P., & Geršl, V. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111468 · Cited by 45
“After some promising initial experience, obtained mostly in acute experimental settings, mixed, contradictive, or solely negative outcomes were reported from both chronic experimental models and clinical studies (Legha et al., 1982; Myers et al., 1983; Herman et al., 1985; Berthiaume et al., 2005).”
Resultdos Santos, R. V. T., Júnior, M. L. B., Caperuto, É. C., & Rosa, L. F. C. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04717.x · Cited by 44
Gao, S., Li, H., Cai, Y., Ye, J., Liu, Z., Lü, J., Huang, X., Feng, X., Gao, H., Chen, S., et al. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.12.008 · Cited by 44
Rodrigo, R., Miranda-Merchak, A., Grau, R. V., Bachler, J. P., & Vergara, L. (2013) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2013.783048 · Cited by 43
Reis-Mendes, A., Padrão, A. I., Duarte, J. A., Gonçalves‐Monteiro, S., Duarte‐Araújo, M., Remião, F., Carvalho, F. D., Sousa, E., Bastos, M. D. L., & Costa, V. M. (2021) · Biomolecules · doi:10.3390/biom11111725 · Cited by 43
“Several studies demonstrated that DOX causes an increase in protein carbonyl groups in cardiac tissue [36,37,60].”
BackgroundMachado, N. G., Alves, M. G., Carvalho, R. A., & Oliveira, P. J. (2009) · Cardiovascular Toxicology · doi:10.1007/s12012-009-9055-1 · Cited by 43
“We have demonstrated that atocopherol succinate, despite a recognized antioxidant activity in the liver, could not be accumulated in effective concentrations in cardiac mitochondria in order to prevent doxorubicin oxidative damage [175].”
BackgroundSelf-citationPereira, G. C., Pereira, S. P., Pereira, C. V., Lumini‐Oliveira, J., Magalhães, J., Ascensão, A. A. M. R., Santos, M. S., Moreno, A. J., & Oliveira, P. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038867 · Cited by 42
“Interestingly, the results from Sprague-Dawley [6,9,27] and Wistar rats (our study) suggest that the former are more susceptible to DOX cardiotoxicity.”
BackgroundResultSelf-citationCancer treatment-related cardiac toxicity: prevention, assessment and management
Fanous, I. S., & Dillon, P. M. (2016) · Medical Oncology · doi:10.1007/s12032-016-0801-5 · Cited by 41
Drug-induced mitochondrial dysfunction in cardiac and skeletal muscle injury
Sardão, V. A., Pereira, S. L., & Oliveira, P. J. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.2.129 · Cited by 40
Self-citationBodiga, V. L., Bodiga, S., Surampudi, S., Sesikeran, B., Udaykumar, P., Balakrishna, N., Subramaniam, K., & Raghunath, M. (2011) · Nutrition · doi:10.1016/j.nut.2011.09.007 · Cited by 40
Ascensão, A. A. M. R., Ferreira, R. M., Oliveira, P. J., & Magalhães, J. (2006) · Cardiovascular Toxicology · doi:10.1385/ct:6:3:159 · Cited by 39
“The most apparent intriguing finding of the present study was that, as opposed to what was expected and previously observed against other in vitro stimuli such as calcium (10,34, 35 ), ADR may prevent (with the exception of state 3) mitochondrial respiratory dysfunction induced by AR. In the setup conditions of the pr…”
ResultSelf-citationA pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy
Xiong, S., Wang, Z., Liu, J., Deng, X., Xiong, R., Cao, X., Xie, Z., Lei, X., Chen, Y., & Tang, G. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.10.012 · Cited by 37
Richard, C., Lauzier, B., Delemasure, S., Talbot, S., Ghibu, S., Collin, B., Sénécal, J., Ménétrier, F., Vergely, C., Couture, R., et al. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181865f28 · Cited by 36
Doxorubicin-Induced Oxidative Injury of Cardiomyocytes - Do We Have Right Strategies for Prevention?
Torres, V. M., & Dragojevic, V. (2012) · InTech eBooks · doi:10.5772/34692 · Cited by 35
“These findings suggested that tocopherol enrichment is not sufficient to protect cardiac mitochondrial membranes from DOX induced toxicity (Berthiaume et al., 2005).”
BackgroundŠtěrba, M., Popelová, O., Šimůnek, T., Mazurová, Y., Potáčová, A., Adamcová, M., Němečková, I., Mertlíková‐Kaiserová, H., Palička, V., Poňka, P., et al. (2007) · Toxicology · doi:10.1016/j.tox.2007.03.020 · Cited by 35
Treatment of mitochondrial disorders
Finsterer, J. (2009) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2009.07.005 · Cited by 31
“vitamin E was ineffective to protect cardiomyocytes from doxorubicin-induced toxicity.(57)”
Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
Abrahams, C., Woudberg, N. J., & Lecour, S. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01694-y · Cited by 27
“However, in preclinical studies the use of anti-oxidants are not able to protect against DOX-induced cardiotoxicity doubting the role of generating reactive oxygen species (ROS) as the main mechanism for toxicity [19, 20].”
BackgroundOxidative Stress in Dog with Heart Failure: The Role of Dietary Fatty Acids and Antioxidants
Sagols, E., & Priymenko, N. (2011) · Veterinary Medicine International · doi:10.4061/2011/180206 · Cited by 27
“In a study led in rats, a vitamin E supplementation allows an increase of its incorporation in the cell membranes and a decrease of the quantity of proteins oxidized in cells [19].”
BackgroundCzepas, J., & Gwoździński, K. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.10.013 · Cited by 25
Danmaigoro, A., Selvarajah, G. T., Noor, M. H. M., Mahmud, R., & Zakaria, M. Z. A. B. (2018) · Advances in Pharmacological Sciences · doi:10.1155/2018/4848602 · Cited by 25
Phylogenetic origin of LI-cadherin revealed by protein and gene structure analysis
Jung, R., Wendeler, M. W., Danevad, M., Himmelbauer, H., & Gessner, R. V. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-3470-z · Cited by 25
Cardiotoxicity of Oncologic Treatments
Fiúza, M. (2012) · InTech eBooks · doi:10.5772/2170 · Cited by 23
Hu, Y., Guo, Z., Lü, J., Wang, P., Sun, S., Zhang, Y., Li, J., Zheng, Q., Guo, K., Wang, J., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2342-5 · Cited by 21
Reis-Mendes, A., Ferreira, M., Duarte, J. A., Duarte‐Araújo, M., Remião, F., Carvalho, F. D., Sousa, E., Bastos, M. D. L., & Costa, V. M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03586-1 · Cited by 20
“Similar results were reported in our previous work (Reis-Mendes et al. 2021b) and by other authors (Berthiaume et al. 2005; Huang et al. 2021; Iwasaki and Suzuki 1991; Koti et al. 2013; Oliveira et al. 2004; Papadopoulou et al. 1999; Shaker et al. 2018; Wu et al. 2019b; Zhao et al. 2018), but never…”
ResultReis-Mendes, A., Ferreira, M., Padrão, A. I., Duarte, J. A., Duarte‐Araújo, M., Remião, F., Carvalho, F. D., Sousa, E., Bastos, M. D. L., & Costa, V. M. (2023) · Inflammation · doi:10.1007/s10753-023-01908-0 · Cited by 20
“Nonetheless, we observed that protein oxidation by carbonylation was not seen in the 1W-DOX group, possibly because of the lower cumulative dose, when compared to previous studies [19, 37, 38, 56, 57], in which increased cardiac protein car-bonylation was seen.”
ResultConcurrent use of antioxidants in cancer therapy: an update
Akbas, H. S., Timur, M., & Özben, T. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.6.931 · Cited by 20
Rashikh, M. A., Pillai, K. K., & Najmi, A. K. (2013) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12054 · Cited by 20
Erianin alleviates doxorubicin-induced cardiotoxicity by activating the Keap1-Nrf2 signaling pathway
Kang, S., Li, H., Li, M., Zhao, Y., Pang, J., Dan, J., & Sheng, M. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156684 · Cited by 17
Recent progress in the role of endogenous metal ions in doxorubicin-induced cardiotoxicity
Zhou, N., Wei, S., Sun, T., Xie, S., Liu, J., Li, W., & Zhang, B. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1292088 · Cited by 17
“…cardiac dysfunction caused by ferroptosis can be inhibited by iron complexing agents and antioxidants such as Ferrostatin-1 (Baba et al., 2018), Dexrazoxane (Weiss et al., 1999), Deferoxamine (Menon and Kim, 2022), Deferiprone (El-Ammar el et al., 2011), and Vitamin E (Berthiaume et al., 2005).”
BackgroundMachado, N. G., Baldeiras, I., Pereira, G. C., Pereira, S. P., & Oliveira, P. J. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.09.027 · Cited by 16
Self-citationKondru, S. K., Potnuri, A. G., Allakonda, L., & Konduri, P. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3175-x · Cited by 15
“Controlling oxidative stress by administering antioxidants like monoHER, N acetylcysteine, Vitamin E and caffeic acid was found to be associated with a positive outcome highlighting the significance of oxidative stress [9, 41].”
BackgroundCindrić, M., Cipak, A., Serly, J., Plotniece, A., Jaganjac, M., Mrakovčić, L., Lovaković, T., Dedić, A., Soldo, I., Duburs, G., et al. (2010) · PubMed · Cited by 15
Korean Red Ginseng enhances cardiac hemodynamics on doxorubicin-induced toxicity in rats
Jang, Y.-J., Lee, D., Hossain, M. A., Aravinthan, A., Kang, C. W., Kim, N. S., & Kim, J. (2019) · Journal of Ginseng Research · doi:10.1016/j.jgr.2019.03.002 · Cited by 13
Resistance Training during Chemotherapy with Doxorubicin
Bredahl, E. C., Sharif, S. A. I., Siedlik, J. A., Wagner, M. K., Twaddell, M., Tigner, A., Dovgan, M., Najdawi, W., Hydock, D. S., Eckerson, J. M., et al. (2020) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002409 · Cited by 13
“Most treatment programs designed tominimize the side effects of DOX include a combination of nutrition and drug therapy (12,13); however, there is emerging evidence for the role of exercise as an adjuvant therapy before, during, and after cancer treatment (2,14,15).”
BackgroundИндуцированная антрациклинами кардиотоксичность: механизмы развития и клинические проявления
Матяш, М. Г., Кравчук, Т. Л., Высоцкая, В. В., Чернов, В. И., & Goldberg, V. E. (2008) · Siberian Journal of Oncology · Cited by 10
Can antioxidant vitamins avoid the cardiotoxicity of doxorubicin in treating breast cancer?
Cavalcanti, I. D. L., Medeiros, S. M. D. F. R. D. S., Medeiros, S. M. D. F. R. D. S., Cavalcanti, I. M. F., & Nogueira, M. C. D. B. L. (2021) · PharmaNutrition · doi:10.1016/j.phanu.2021.100259 · Cited by 9
Moustafa, I., Saka, S. A., Viljoen, M., & Oosthuizen, F. (2022) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552221078284 · Cited by 7
Aqueous Extract of Andrographis paniculata Ameliorates Cardiotoxicity Induced by Doxorubicin in vivo
Wang, H., Yu, X., Xun, Z., & Wu, Y. (2022) · International Journal of Pharmacology · doi:10.3923/ijp.2022.466.474 · Cited by 5
Mitochondria as a Biosensor for Drug-induced Toxicity – Is It Really Relevant?
Oliveira, Moreira, A. C., Machado, N. J., Bernardo, T. C., & Sardão, V. A. (2011) · InTech eBooks · doi:10.5772/17805 · Cited by 5
Molecular Mechanisms of Anthracycline-Induced Cardiotoxicity
Moudgil, R., & Yeh, E. T. H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803547-4.00004-5 · Cited by 5
Aspects related to oxidative stress-mediated toxicity of doxorubicin during chemotherapy treatment
de Campos, F. C., Panis, C., Rossi, T. D., Victorino, V. J., Cecchini, A. L., & Cecchini, R. (2012) · Applied cancer research/Applied Cancer Research · Cited by 4
Jiang, Y., Zhang, J., Zeng, L., Li, Y., Wang, D., Li, Y., Sun, L., & Fan, F. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104330 · Cited by 2
“Finally, salidroside inhibits DOX-induced cardiomyopathy by regulating ferroptosis-dependent pathways [202]. α -tocopherol ( α -Toc), a well-known antioxidant, can effectively prevent lipid peroxidation and alleviate DOX-induced cardiotoxicity [203 – 206].”
Cardiovascular Complications of Chemotherapy: Anthracycline Cardiotoxicity
Russell, R. R. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4441-0_26 · Cited by 2
The Effect of β-Carotene Against Adriamycin Toxicity on the Embryo Formation
Žalgevičienė, V., Graželienė, G., Žukienė, J., & Didžiapetrienė, J. (2011) · Medicina · doi:10.3390/medicina47010007 · Cited by 2
“Dietary vitamin E decreases doxorubicin-induced oxidative stress, but is not responsible for persistent mitochondrial cardiomyopathy caused by long-term doxorubicin therapy (12).”
BackgroundDoxyl Nitroxide Spin Probes Can Modify Toxicity of Doxorubicin towards Fibroblast Cells
Czepas, J., Matczak, K., Koceva‐Chyła, A., Grobelski, B., Jóźwiak, Z., & Gwoździński, K. (2020) · Molecules · doi:10.3390/molecules25215138 · Cited by 2
“It has been shown that, although α-Tocopherol incorporates into cardiac lipid membranes and protects from oxidative stress, it does not shield against an impairment of mitochondrial function and histopathology of cardiomyocytes [31].”
BackgroundHeart Response to Inflammation and Infection
Marín-García, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012373698-7/50014-0 · Cited by 2
Azzam, S. M., Salem, G. E. M., Rahman, A. A. S. A., Refaat, M. M., Darwish, I. A., Tongdeesoontorn, W., Aleskandarany, M. A., & Darwish, A. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.150571 · Cited by 1
Machado, N. G., Baldeiras, I., Pereira, G. C., Pereira, S. P., & Oliveira, P. J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.10.101 · Cited by 1
Self-citationA IMPORTÂNCIA DA CARDIO-ONCOLOGIA NA PREVENÇÃO DE EVENTOS CARDIOVASCULARES NO TRATAMENTO DO CÂNCER
de Siqueira, E. F., Guimarães, F. V., Dorvalino, J. D. S., Scalfi, L. C. M., & Taglietti, Z. R. (2023) · EPITAYA eBooks · doi:10.47879/ed.ep.2023809p312 · Cited by 1
Efecto del hidroxitirosol sobre la cardiotoxicidad producida por doxorubicina
de Haro, N. (2013) · Institutional Repository of the University of Granada (University of Granada) · Cited by 1
Efecto de la cerveza frente al estrés oxidativo inducido por la adriamicina.
Rodríguez, T., & Carmen, M. (2007) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia) · Cited by 1
Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
Haupt, L. P. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6834 · Cited by 1
A matter of life or death : autophagy in the context of prolonged doxorubicin therapy
Adonis, M. (2019) · SUNScholar (Stellenbosch University) · Cited by 1
Félix, D. N. M. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/veen-rx15 · Cited by 1
ALIMENTATION DU CHIEN ET DU CHAT INSUFFISANT CARDIAQUE
Sagols, M., Priymenko, M. N., & Henroteaux, M. (2007)
Does cardioprotection by autophagy go beyond acute cardiotoxicity
Chabaesele, I. (2016) · SUNScholar (Stellenbosch University)
Metadata
- Authors
- Berthiaume, J. M., Oliveira, P. J., Fariss, M. W., & Wallace, K. B.
- Affiliations
- University of Minnesota (US)
- University of Coimbra (PT)
- University of Colorado Health (US)
- Corresponding author
- Berthiaume, J. M.
- Venue
- Cardiovascular Toxicology
- Published
- 2005
- Volume
- 5
- Issue
- 3
- Pages
- 257-268
- ISSN
- 1530-7905 (ISSN-L)
- OpenAlex
- W1966078661
- Cited by
- 101
- References
- 42
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 5 · 2022: 11 · 2021: 2 · 2020: 7 · 2019: 5 · 2018: 7 · 2017: 3 · 2016: 2 · 2015: 1 · 2014: 5 · 2013: 8 · 2012: 7
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Cardiovascular Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL58016, R01HL058016)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- doxorubicin, cardiotoxicity, alpha-tocopherol, vitamin E supplementation, oxidative stress, mitochondrial dysfunction, mitochondrial cardiomyopathy
- MeSH terms
- Animals, Antibiotics, Antineoplastic, Body Weight, Calcium, Diet, Doxorubicin, Heart Diseases, Indicators and Reagents, Mitochondria, Heart, Muscle Proteins, Myocardium, Organ Size, Oxygen Consumption, Vitamin E, Vitamins, Rats, Sprague-Dawley, Oxidative Stress, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.